AI assistant
TALPHERA, INC. — Director's Dealing 2011
Feb 10, 2011
35181_dirs_2011-02-10_2ba391be-40f4-445e-bd84-d956552ca6b2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2011-02-10
Reporting Person: Palmer Pamela P (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 250000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $1.32 | 2017-04-03 | Common Stock (25000) | Direct | |
| Stock Option (Right to Buy) | $4.00 | 2018-08-14 | Common Stock (37500) | Direct | |
| Stock Option (Right to Buy) | $5.52 | 2019-07-01 | Common Stock (37500) | Direct | |
| Stock Option (Right to Buy) | $2.56 | 2020-06-15 | Common Stock (250000) | Direct |
Footnotes
F1: Reflects a 1-for-4 reverse stock split of the Company's issued an outstanding securities effective January 28, 2011.
F2: The shares are fully vested.
F3: The shares subject to the option vest as follows: 1/4 of the shares subject to the option vest on December 31, 2007 with the remaining shares subject to the option vesting on an equal monthly basis over the following 36 months.
F4: The shares subject to the option vest as follows: 1/4 of the shares to the option vest on December 31, 2008 with the remaining shares subject to the option vesting on an equal monthly basis over the following 36 months.
F5: The shares subject to the option vest as follows: 1/2 of the shares subject to the option vest on December 31, 2010 with the remaining shares subject to the option vesting on an equal monthly basis over the following 24 months.